Rocket Lab (RKLB) stock surges 6.5% after KeyBanc's upgrade to Overweight with $135 price target. Nasdaq-100 inclusion set for June 22, 2026. The post Rocket LabRocket Lab (RKLB) stock surges 6.5% after KeyBanc's upgrade to Overweight with $135 price target. Nasdaq-100 inclusion set for June 22, 2026. The post Rocket Lab

Rocket Lab (RKLB) Stock Soars 6.5% on KeyBanc Upgrade and Nasdaq-100 Entry Confirmed

2026/06/15 21:56
3분 읽기
이 콘텐츠에 대한 의견이나 우려 사항이 있으시면 crypto.news@mexc.com으로 연락주시기 바랍니다

Key Highlights

  • RKLB received an Overweight rating from KeyBanc with a $135 price target, suggesting approximately 40% potential upside
  • The company’s inclusion in the Nasdaq-100 Index is scheduled for June 22, 2026
  • Neutron rocket development continues on track for debut launch this year following resolution of January testing issue
  • First quarter revenue reached $200.35 million, representing a 63.4% year-over-year increase and surpassing $189.65 million analyst projections
  • Institutional investors hold 71.78% of shares, with several major funds expanding positions during Q1

Rocket Lab (RKLB) shares are changing hands at $102.39, marking a 6.50% gain on Monday, driven by a bullish analyst reassessment and the company’s confirmed addition to a major stock index.


RKLB Stock Card
Rocket Lab USA, Inc., RKLB

KeyBanc elevated its rating on RKLB to Overweight from Sector Weight while establishing a $135 price target. This valuation implies approximately 40% appreciation potential from current trading levels. The analyst firm maintained its existing financial projections.

The timing of the upgrade aligns with Rocket Lab‘s scheduled entry into the Nasdaq-100 on June 22. Such index additions typically generate buying pressure from over 200 exchange-traded and index funds tracking the benchmark, which manage more than $800 billion in combined assets.

KeyBanc highlighted Rocket Lab’s standing as the number two competitor in the commercial orbital launch industry. The company’s Electron vehicle has achieved approximately 90 successful orbital missions to date.

For many analysts, the Neutron rocket program represents the more significant catalyst. KeyBanc indicated it has developed improved clarity on the program’s status during recent months and verified that a January testing setback has been completely addressed. The Neutron vehicle remains scheduled for its inaugural flight within this calendar year.

Stifel recently boosted its RKLB price objective to $132 from $110 while reaffirming its Buy recommendation, pointing to robust revenue growth and an expanding contract pipeline.

First Quarter Performance Exceeds Projections

On May 7, Rocket Lab disclosed Q1 revenue totaling $200.35 million, surpassing the $189.65 million Wall Street consensus. This figure represented a 63.4% increase compared to the prior-year quarter.

Earnings per share registered at -$0.07, aligning with analyst expectations. The company recorded a net margin of negative 26.87% alongside a negative return on equity of 11.72%. Full-year EPS is projected at -$0.29 by the analyst community.

Shares have rocketed more than 300% over the trailing twelve months. The stock reached a 52-week peak of $151.00 and touched a low of $25.24, currently trading roughly 24% beneath its recent high. The 50-day moving average stands at $101.62.

Institutional Investors Continue Building Positions

Institutional stakeholders control 71.78% of outstanding RKLB shares. During Q1, AQR Capital Management expanded its holdings by more than 100%, purchasing an additional 92,849 shares. NewEdge Advisors boosted its position by over 1,800%. UBS Asset Management acquired 90,758 shares, elevating its total ownership to 773,548.

Entropy Technologies LP grew its stake by 18.5% in Q4, bringing its holdings to 55,117 shares valued at approximately $3.85 million.

Regarding insider transactions, Director Alexander Slusky divested 100,000 shares on May 12 at $118.08, trimming his stake by 18.7%. Insider Marvin Bradford Clevenger sold 15,549 shares on May 26 at $142.57, with the transaction attributed to tax withholding requirements on vested equity compensation.

Wall Street sentiment skews positive overall. Twelve analysts assign a Buy rating, three rate it Strong Buy, five recommend Hold, and one suggests Sell. The average price target among analysts is $102.76.

The equity has also gained from increased investor focus on space industry equities following SpaceX’s recent Nasdaq listing, prompting capital flows into aerospace-related stocks.

The post Rocket Lab (RKLB) Stock Soars 6.5% on KeyBanc Upgrade and Nasdaq-100 Entry Confirmed appeared first on Blockonomi.

시장 기회
LAB 로고
LAB 가격(LAB)
$9.95887
$9.95887$9.95887
-2.68%
USD
LAB (LAB) 실시간 가격 차트

World Cup Combo: Aim for 200x

World Cup Combo: Aim for 200xWorld Cup Combo: Aim for 200x

Combine up to 20 World Cup matches in one order

면책 조항: 본 사이트에 재게시된 글들은 공개 플랫폼에서 가져온 것으로 정보 제공 목적으로만 제공됩니다. 이는 반드시 MEXC의 견해를 반영하는 것은 아닙니다. 모든 권리는 원저자에게 있습니다. 제3자의 권리를 침해하는 콘텐츠가 있다고 판단될 경우, crypto.news@mexc.com으로 연락하여 삭제 요청을 해주시기 바랍니다. MEXC는 콘텐츠의 정확성, 완전성 또는 시의적절성에 대해 어떠한 보증도 하지 않으며, 제공된 정보에 기반하여 취해진 어떠한 조치에 대해서도 책임을 지지 않습니다. 본 콘텐츠는 금융, 법률 또는 기타 전문적인 조언을 구성하지 않으며, MEXC의 추천이나 보증으로 간주되어서는 안 됩니다.

Score Your Share of 50K USDT

Score Your Share of 50K USDTScore Your Share of 50K USDT

Complete DEX+ tasks to unlock the Champion Wheel